I-Dipeptide Diaminobutyroyl Benzylamide Diacetate 823202-99-9
Inkokhelo:T/T, L/C
Umsuka Womkhiqizo:China
Imbobo yokuthutha:Beijing/Shanghai/Hangzhou
I-oda(MOQ): 1g
Isikhathi esiholayo:3 Izinsuku Zokusebenza
Amandla okukhiqiza:40kg/ngenyanga
Isimo sesitoreji:nesikhwama seqhwa sokuthutha, 2-8℃ sokugcina isikhathi eside
Impahla yephakheji:ibhodlela, ibhodlela
Usayizi wephakheji:1g/ibhodlela, 5/ibhodlela, 10g/ibhodlela, 50g/ibhodlela, 500g/ibhodlela

Isingeniso
I-Syn-ake iyisithako esinelungelo lobunikazi sokulwa nokuguga esakhiwe inkampani yaseSweden, i-Pentapharm Ltd, eklanyelwe ukulingisa isenzo sobuthi benyoka.Yenzelwe ukusebenzela ukuphumula imisipha ebusweni ukuze kuncishiswe ukubukeka kwemibimbi nemigqa emihle.
I-Syn-ake iyi-peptide yokwenziwa noma i-syn-peptide.Ama-Syn peptides angamaphrotheni amancane okwenziwa amodelwa ku-peptide engeyona yokwenziwa noma yomhlaba wangempela.Endabeni ye-Syn-ake, i-peptide yokwenziwa eyenziwe imodeli yeprotheni etholakala ebuhlungwini be-Temple Viper.I-peptide elingisa i-Syn-ake i-Waglerin-1.I-Waglerin-1 ivimbela ukutholwa kwe-sodium ngemisipha ngokusebenza ku-mnAchR receptor.Ukuvimbela ukutholwa kwe-sodium kuvimbela ukudluliselwa kwemizwa yezinzwa emisipha, futhi imisipha ihlale ikhululekile.Lokhu kuphumula kwemisipha, okufana ne-Botox, kunciphisa ukubukeka kwemigqa emihle nemibimbi.
Njengesithako se-skincare, i-Syn-ake ingangezwa ezinhlotsheni eziningi zokwakheka, njengama-serum, ama-moisturizers, noma imikhiqizo eminingi esekwe emanzini.Ngokuvamile isetshenziswa njengezithako eziyinhloko zokulwa nokuguga kodwa futhi ingakhiwa kanye nezinye izithako ezibalulekile ukuze kwakhiwe umkhiqizo ophikisana nokuguga ohluke kakhulu.
Ukucaciswa (ubumsulwa bukhuphuke ngo-98% nge-HPLC)
IZINTO ZOKUHLOLA | INKCAZO |
Aukubonakala | Impushana emhlophe noma ecishe ibe mhlophe |
Mi-olecularI-ion mass | 495.58±1 |
Pubunye(HPLC) | I-NLT 98% |
Izinto ezihlobene (I-HPLC) | Ukungcola okuphelele: NMT 2.0% Noma yikuphi ukungcola: NMT 1.0% |
Acetici-asidi (HPLC) | I-NLT 20% |
Amanzi (U-Karl fishcer) | I-NMT 8.0% |